Editas Medicine

In News

Editas Medicine (NASDAQ:EDIT) Share Price Crosses Below Fifty Day Moving Average - Time to Sell? - MarketBeat

MarketBeat - Feb 13, 2026

Companies Like Editas Medicine (NASDAQ:EDIT) Could Be Quite Risky - Yahoo Finance

Yahoo Finance - Feb 09, 2026

Editas Medicine: Three Strikes And It's Out, Or Third Time’s The Charm? - Seeking Alpha

Seeking Alpha - Oct 14, 2025

Individual investors who hold 55% of Editas Medicine, Inc. (NASDAQ:EDIT) gained 14%, institutions profited as well - simplywall.st

simplywall.st - Jan 23, 2026

Why Editas Medicine Inc. (8EM) stock could be next leader - July 2025 Trade Ideas & AI Driven Price Predictions - mfd.ru

mfd.ru - Feb 14, 2026

After strategic pivot, Editas lays out plan to target high cholesterol with gene editing - Fierce Biotech

Fierce Biotech - Sep 02, 2025

Editas Medicine Is Great. Here's Why You Shouldn't Buy It. - The Motley Fool

The Motley Fool - Jun 17, 2025

Editas Medicine’s Volatile Comeback: Can CRISPR Hype Outrun Clinical Risk? - AD HOC NEWS

AD HOC NEWS - Feb 13, 2026

Editas Medicine at Chardan’s Conference: Gene Editing Insights - Investing.com

Investing.com - Oct 21, 2025

Aug Movers: Can Editas Medicine Inc. outperform in the next rally - Earnings Risk Report & Reliable Volume Spike Trade Alerts - mfd.ru

mfd.ru - Feb 14, 2026

Editas Medicine Announces Second Quarter 2025 Results and Business Updates - Yahoo Finance

Yahoo Finance - Aug 12, 2025

Why Editas Medicine Stock Was Skyrocketing This Week - The Motley Fool

The Motley Fool - Aug 15, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment